Protagonist Historical Balance Sheet

PTGX Stock

USD 43.80 1.15 2.56%

Trend analysis of Protagonist Therapeutics balance sheet accounts such as Other Liabilities of 132.2 K, Net Tangible Assets of 141.3 M, Property Plant And Equipment Net of 3.4 M or Accounts Payable of 733.4 K provides information on Protagonist Therapeutics' total assets, liabilities, and equity, which is the actual value of Protagonist Therapeutics to its prevalent stockholders. By breaking down trends over time using Protagonist Therapeutics balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Covid

Financial Statement Analysis is much more than just reviewing and examining Protagonist Therapeutics latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Protagonist Therapeutics is a good buy for the upcoming year.

Protagonist Therapeutics Inventory

(9.82 Million)

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Protagonist Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.

For more information on how to buy Protagonist Stock please use our How to Invest in Protagonist Therapeutics guide.

About Protagonist Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Protagonist Therapeutics at a specified time, usually calculated after every quarter, six months, or one year. Protagonist Therapeutics Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Protagonist Therapeutics and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Protagonist currently owns. An asset can also be divided into two categories, current and non-current.

Protagonist Therapeutics Balance Sheet Chart

At this time, Protagonist Therapeutics' Capital Surpluse is fairly stable compared to the past year. Short Term Debt is likely to rise to about 3.1 M in 2024, whereas Total Assets are likely to drop slightly above 204.1 M in 2024.

Total Assets Total Current Liabilities Other Liab Preferred Stock Total Equity Capital Stock Capital Lease Obligations

Add Fundamental

Total Assets

Total assets refers to the total amount of Protagonist Therapeutics assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Protagonist Therapeutics books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Protagonist Therapeutics balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Protagonist Therapeutics are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Capital Stock

The total amount of a company's capital funded by shareholders through the issue and subscription of shares.

Capital Lease Obligations

Protagonist Therapeutics capital lease obligations are the amount due for long-term lease agreements that are nearly equivalent to Protagonist Therapeutics asset purchases. For example, Protagonist Therapeutics can use a capital lease to finance the purchase of an asset without ever buying it. A capital lease gives companies such as Protagonist Therapeutics control over an asset for a big portion of its life. The total obligations of a company under capital leases, which are lease agreements that transfer substantially all risks and rewards of ownership to the lessee.

Most accounts from Protagonist Therapeutics' balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Protagonist Therapeutics current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Protagonist Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.

For more information on how to buy Protagonist Stock please use our How to Invest in Protagonist Therapeutics guide.At this time, Protagonist Therapeutics' Capital Surpluse is fairly stable compared to the past year. Short Term Debt is likely to rise to about 3.1 M in 2024, whereas Total Assets are likely to drop slightly above 204.1 M in 2024.

	2021	2022	2023	2024 (projected)
Cash	123.7M	125.7M	186.7M	196.1M
Accounts Payable	1.6M	3.6M	772K	733.4K

Cash Accounts Payable

Protagonist Therapeutics balance sheet Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Other Assets	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Short Term Investments	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Long Term Investments	Property Plant And Equipment Gross	Total Current Assets	Common Stock
Total Assets		0.81	0.83	-0.25	-0.04	0.99	0.72	-0.87	-0.85	0.39	0.87	0.52	0.25	1.0	0.5	0.94	0.96	0.23	-0.03	0.83	0.82	0.3	-0.8	0.87	1.0	0.1
Other Current Liab	0.81		0.61	-0.35	-0.51	0.86	0.43	-0.75	-0.68	0.28	0.72	0.31	-0.2	0.82	0.11	0.76	0.77	0.31	0.07	0.9	0.75	0.35	-0.56	0.67	0.81	0.09
Total Current Liabilities	0.83	0.61		-0.45	0.2	0.83	0.77	-0.69	-0.62	0.55	0.71	0.71	0.54	0.82	0.4	0.73	0.79	0.21	0.11	0.69	0.5	0.29	-0.69	0.72	0.82	0.21
Total Stockholder Equity	-0.25	-0.35	-0.45		-0.16	-0.35	-0.52	-0.09	0.0	-0.57	0.09	-0.58	-0.26	-0.24	0.53	-0.24	-0.32	-0.56	-0.67	-0.47	0.07	-0.59	0.22	-0.39	-0.24	-0.01
Other Liab	-0.04	-0.51	0.2	-0.16		-0.12	0.49	0.28	0.05	0.19	-0.22	0.24	0.81	-0.07	0.23	-0.01	0.05	-0.05	0.31	-0.19	-0.26	-0.03	-0.24	0.22	-0.05	0.08
Net Tangible Assets	0.99	0.86	0.83	-0.35	-0.12		0.7	-0.84	-0.81	0.44	0.83	0.56	0.2	0.99	0.39	0.91	0.96	0.28	0.02	0.87	0.79	0.34	-0.77	0.84	0.98	0.03
Property Plant And Equipment Net	0.72	0.43	0.77	-0.52	0.49	0.7		-0.41	-0.59	0.41	0.46	0.54	0.55	0.7	0.26	0.68	0.83	0.26	0.44	0.72	0.51	0.32	-0.75	0.86	0.71	0.19
Net Debt	-0.87	-0.75	-0.69	-0.09	0.28	-0.84	-0.41		0.91	-0.26	-1.0	-0.3	-0.07	-0.87	-0.66	-0.86	-0.74	-0.23	0.39	-0.63	-0.89	-0.28	0.71	-0.66	-0.87	-0.19
Retained Earnings	-0.85	-0.68	-0.62	0.0	0.05	-0.81	-0.59	0.91		-0.25	-0.92	-0.28	-0.14	-0.86	-0.64	-0.92	-0.8	-0.41	0.24	-0.66	-0.95	-0.45	0.84	-0.85	-0.86	-0.17
Accounts Payable	0.39	0.28	0.55	-0.57	0.19	0.44	0.41	-0.26	-0.25		0.26	0.38	0.64	0.39	0.17	0.4	0.37	0.38	0.35	0.24	0.08	0.42	-0.62	0.32	0.39	0.08
Cash	0.87	0.72	0.71	0.09	-0.22	0.83	0.46	-1.0	-0.92	0.26		0.31	0.12	0.87	0.69	0.86	0.76	0.22	-0.37	0.63	0.89	0.27	-0.74	0.69	0.87	0.2
Non Current Assets Total	0.52	0.31	0.71	-0.58	0.24	0.56	0.54	-0.3	-0.28	0.38	0.31		0.36	0.51	0.04	0.39	0.5	0.37	-0.06	0.39	0.2	0.42	-0.25	0.44	0.49	-0.36
Other Assets	0.25	-0.2	0.54	-0.26	0.81	0.2	0.55	-0.07	-0.14	0.64	0.12	0.36		0.23	0.46	0.25	0.27	-0.02	0.28	-0.02	-0.11	0.03	-0.54	0.31	0.24	0.17
Cash And Short Term Investments	1.0	0.82	0.82	-0.24	-0.07	0.99	0.7	-0.87	-0.86	0.39	0.87	0.51	0.23		0.49	0.94	0.96	0.24	-0.04	0.83	0.83	0.3	-0.79	0.86	1.0	0.1
Net Receivables	0.5	0.11	0.4	0.53	0.23	0.39	0.26	-0.66	-0.64	0.17	0.69	0.04	0.46	0.49		0.5	0.42	-0.22	-0.49	0.08	0.53	-0.19	-0.62	0.35	0.5	0.07
Common Stock Shares Outstanding	0.94	0.76	0.73	-0.24	-0.01	0.91	0.68	-0.86	-0.92	0.4	0.86	0.39	0.25	0.94	0.5		0.88	0.43	-0.02	0.76	0.85	0.48	-0.86	0.92	0.95	0.24
Short Term Investments	0.96	0.77	0.79	-0.32	0.05	0.96	0.83	-0.74	-0.8	0.37	0.76	0.5	0.27	0.96	0.42	0.88		0.18	0.14	0.89	0.79	0.24	-0.8	0.9	0.96	0.05
Non Current Liabilities Total	0.23	0.31	0.21	-0.56	-0.05	0.28	0.26	-0.23	-0.41	0.38	0.22	0.37	-0.02	0.24	-0.22	0.43	0.18		0.07	0.25	0.33	1.0	-0.32	0.45	0.22	0.08
Inventory	-0.03	0.07	0.11	-0.67	0.31	0.02	0.44	0.39	0.24	0.35	-0.37	-0.06	0.28	-0.04	-0.49	-0.02	0.14	0.07		0.31	-0.27	0.08	-0.16	0.21	-0.03	0.33
Other Current Assets	0.83	0.9	0.69	-0.47	-0.19	0.87	0.72	-0.63	-0.66	0.24	0.63	0.39	-0.02	0.83	0.08	0.76	0.89	0.25	0.31		0.73	0.3	-0.62	0.82	0.83	0.12
Other Stockholder Equity	0.82	0.75	0.5	0.07	-0.26	0.79	0.51	-0.89	-0.95	0.08	0.89	0.2	-0.11	0.83	0.53	0.85	0.79	0.33	-0.27	0.73		0.36	-0.71	0.78	0.82	0.09
Total Liab	0.3	0.35	0.29	-0.59	-0.03	0.34	0.32	-0.28	-0.45	0.42	0.27	0.42	0.03	0.3	-0.19	0.48	0.24	1.0	0.08	0.3	0.36		-0.37	0.5	0.29	0.09
Long Term Investments	-0.8	-0.56	-0.69	0.22	-0.24	-0.77	-0.75	0.71	0.84	-0.62	-0.74	-0.25	-0.54	-0.79	-0.62	-0.86	-0.8	-0.32	-0.16	-0.62	-0.71	-0.37		-0.83	-0.8	-0.24
Property Plant And Equipment Gross	0.87	0.67	0.72	-0.39	0.22	0.84	0.86	-0.66	-0.85	0.32	0.69	0.44	0.31	0.86	0.35	0.92	0.9	0.45	0.21	0.82	0.78	0.5	-0.83		0.87	0.21
Total Current Assets	1.0	0.81	0.82	-0.24	-0.05	0.98	0.71	-0.87	-0.86	0.39	0.87	0.49	0.24	1.0	0.5	0.95	0.96	0.22	-0.03	0.83	0.82	0.29	-0.8	0.87		0.12
Common Stock	0.1	0.09	0.21	-0.01	0.08	0.03	0.19	-0.19	-0.17	0.08	0.2	-0.36	0.17	0.1	0.07	0.24	0.05	0.08	0.33	0.12	0.09	0.09	-0.24	0.21	0.12

Click cells to compare fundamentals

Protagonist Therapeutics Account Relationship Matchups

Protagonist Therapeutics balance sheet Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	154.9M	324.5M	347.7M	247.9M	358.0M	204.1M
Other Current Liab	(10.2M)	19.8M	36.4M	22.5M	18.2M	12.7M
Total Current Liabilities	35.4M	40.2M	44.0M	31.2M	21.3M	27.7M
Total Stockholder Equity	(217.7M)	(283.8M)	(409.4M)	(536.8M)	336.7M	353.5M
Net Tangible Assets	80.0M	279.6M	300.0M	215.6M	247.9M	141.3M
Property Plant And Equipment Net	7.7M	6.4M	6.7M	4.6M	2.1M	3.4M
Net Debt	(16.0M)	(111.4M)	(117.8M)	(122.1M)	(185.6M)	(176.3M)
Retained Earnings	(217.7M)	(283.8M)	(409.4M)	(536.8M)	(615.7M)	(584.9M)
Accounts Payable	2.8M	3.1M	1.6M	3.6M	772K	733.4K
Cash	33.0M	117.4M	123.7M	125.7M	186.7M	196.1M
Non Current Assets Total	9.6M	8.9M	7.0M	10.6M	2.4M	2.3M
Other Assets	450K	1.1M	1.9M	225K	258.8K	245.8K
Cash And Short Term Investments	133.0M	307.8M	326.9M	237.4M	341.6M	191.4M
Net Receivables	6.8M	2.4M	1.6M	52K	10.3M	10.8M
Common Stock Shares Outstanding	25.9M	34.4M	46.3M	49.0M	56.8M	29.8M
Short Term Investments	100.0M	188.5M	203.2M	111.6M	154.9M	99.8M
Liabilities And Stockholders Equity	(142.7M)	(238.9M)	(361.7M)	247.9M	358.0M	375.8M
Non Current Liabilities Total	39.5M	4.6M	3.7M	784.7M	221K	210.0K
Inventory	4.8M	4.0M	8.5M	(94K)	(10.3M)	(9.8M)
Other Current Assets	744K	7.4M	12.3M	5.7M	3.6M	3.6M
Other Stockholder Equity	221K	563.4M	709.7M	752.7M	952.5M	1.0B
Total Liab	75.0M	44.9M	47.7M	784.7M	21.3M	20.2M
Property Plant And Equipment Gross	7.7M	6.4M	11.0M	9.9M	8.4M	5.1M
Total Current Assets	145.3M	315.6M	340.7M	237.4M	355.6M	196.9M
Accumulated Other Comprehensive Income	(221K)	28K	(299K)	(359K)	(105K)	(110.3K)
Property Plant Equipment	7.7M	1.5M	6.7M	1.6M	1.8M	2.5M
Capital Surpluse	297.8M	563.4M	709.7M	752.7M	865.6M	908.9M
Retained Earnings Total Equity	(217.7M)	(283.8M)	(409.4M)	(536.8M)	(483.1M)	(458.9M)
Current Deferred Revenue	41.5M	14.5M	1.6M	69K	3K	2.9K
Net Invested Capital	89.8M	279.6M	300.0M	215.6M	336.7M	228.6M
Net Working Capital	109.9M	275.4M	296.7M	211.9M	334.3M	227.5M
Short Term Debt	1.3M	2.9M	4.4M	5.0M	2.3M	3.1M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

V	Visa Class A
GOOG	Alphabet Inc Class C
GOOG	Alphabet Inc Class C

Additional Tools for Protagonist Stock Analysis

When running Protagonist Therapeutics' price analysis, check to measure Protagonist Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Protagonist Therapeutics is operating at the current time. Most of Protagonist Therapeutics' value examination focuses on studying past and present price action to predict the probability of Protagonist Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Protagonist Therapeutics' price. Additionally, you may evaluate how the addition of Protagonist Therapeutics to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Protagonist Historical Balance Sheet

Protagonist Therapeutics Inventory

(9.82 Million)

About Protagonist Balance Sheet Analysis

Protagonist Therapeutics Balance Sheet Chart

Total Assets

Total Current Liabilities

Capital Stock

Capital Lease Obligations

Protagonist Therapeutics balance sheet Correlations

Protagonist Therapeutics Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Protagonist Therapeutics balance sheet Accounts

Also Currently Popular

Additional Tools for Protagonist Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Total Assets
Total Current Assets	+ 1.0	Total Assets
Total Current Assets	+ 1.0	Cash And Short Term Investments
Total Liab	+ 1.0	Non Current Liabilities Total
Net Tangible Assets	+ 0.99	Total Assets
Cash And Short Term Investments	+ 0.99	Net Tangible Assets

Cash	- 1.0	Net Debt
Other Stockholder Equity	- 0.95	Retained Earnings
Common Stock Shares Outstanding	- 0.92	Retained Earnings
Cash	- 0.92	Retained Earnings
Other Stockholder Equity	- 0.89	Net Debt
Total Current Assets	- 0.87	Net Debt